DK0471525T3 - Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom - Google Patents

Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom

Info

Publication number
DK0471525T3
DK0471525T3 DK91307365.6T DK91307365T DK0471525T3 DK 0471525 T3 DK0471525 T3 DK 0471525T3 DK 91307365 T DK91307365 T DK 91307365T DK 0471525 T3 DK0471525 T3 DK 0471525T3
Authority
DK
Denmark
Prior art keywords
diprenorphine
nalmefene
naltrexone
pure
mast cell
Prior art date
Application number
DK91307365.6T
Other languages
Danish (da)
English (en)
Inventor
Phillip Frost
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Application granted granted Critical
Publication of DK0471525T3 publication Critical patent/DK0471525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91307365.6T 1990-08-10 1991-08-09 Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom DK0471525T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/565,428 US5057322A (en) 1990-08-10 1990-08-10 Method of treating mast cell disease

Publications (1)

Publication Number Publication Date
DK0471525T3 true DK0471525T3 (da) 1996-02-19

Family

ID=24258552

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91307365.6T DK0471525T3 (da) 1990-08-10 1991-08-09 Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom

Country Status (10)

Country Link
US (1) US5057322A (fr)
EP (1) EP0471525B1 (fr)
JP (1) JP2559304B2 (fr)
AT (1) ATE129154T1 (fr)
AU (1) AU8166291A (fr)
CA (1) CA2048894C (fr)
DE (1) DE69113921T2 (fr)
DK (1) DK0471525T3 (fr)
ES (1) ES2078450T3 (fr)
GR (1) GR3018335T3 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648355A (en) * 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
WO1997018781A1 (fr) * 1995-11-20 1997-05-29 University Of Miami Procede pour traiter la dependance a la nicotine
US20030153590A1 (en) * 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454142A (en) * 1983-05-26 1984-06-12 Key Pharmaceuticals, Inc. Hyperkinetic child treatment agent
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
EP0245366A1 (fr) * 1985-10-29 1987-11-19 Baker Cummins Pharmaceuticals, Inc. Procede et composition pour bloquer des reactions allergiques provoquees par des antigenes
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4877791A (en) * 1988-11-01 1989-10-31 Baker Cummins Pharmaceuticals, Inc. Method of treatment for interestitial cystitis
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders

Also Published As

Publication number Publication date
ES2078450T3 (es) 1995-12-16
US5057322A (en) 1991-10-15
CA2048894C (fr) 1995-10-17
DE69113921T2 (de) 1996-05-15
DE69113921D1 (de) 1995-11-23
EP0471525B1 (fr) 1995-10-18
CA2048894A1 (fr) 1992-02-11
ATE129154T1 (de) 1995-11-15
GR3018335T3 (en) 1996-03-31
AU8166291A (en) 1992-02-13
JPH04230629A (ja) 1992-08-19
JP2559304B2 (ja) 1996-12-04
EP0471525A1 (fr) 1992-02-19

Similar Documents

Publication Publication Date Title
IL92269A0 (en) Pharmaceutical composition for treatment of autoimmune diseases
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
DK541189D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
TR200400653T4 (tr) Farmasötik kompozisyonlar.
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
ATE78687T1 (de) Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
DK0471525T3 (da) Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
JPS6483020A (en) Medicinal composition for preventing or treating aids
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
KR880004810A (ko) 소화성 궤양 치료제
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
EP0253777A3 (en) Use of l-carnitine in the treatment of toxic effects induced by the inhalation of halotane and other halogen-containing general anesthetics
RU97122232A (ru) Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
ES2114681T3 (es) Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado.
UA30654A (uk) Спосіб лікування посттравматичних дисфункцій висково- нижньощелепового суглоба
CA2153570A1 (fr) Composition pharmaceutique permettant de traiter la dependance a la nicotine